Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 507

Similar articles for PubMed (Select 16305294)

1.

Low-dose vitamin K to augment anticoagulation control.

Reese AM, Farnett LE, Lyons RM, Patel B, Morgan L, Bussey HI.

Pharmacotherapy. 2005 Dec;25(12):1746-51.

PMID:
16305294
2.

Prospective study of supplemental vitamin K therapy in patients on oral anticoagulants with unstable international normalized ratios.

Ford SK, Misita CP, Shilliday BB, Malone RM, Moore CG, Moll S.

J Thromb Thrombolysis. 2007 Aug;24(1):23-7. Epub 2007 Feb 24.

PMID:
17323135
3.

Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.

Denas G, Marzot F, Offelli P, Stendardo A, Cucchini U, Russo R, Nante G, Iliceto S, Pengo V.

J Thromb Thrombolysis. 2009 Apr;27(3):340-7. doi: 10.1007/s11239-008-0211-4. Epub 2008 Mar 13.

PMID:
18338109
4.

Retrospective and prospective analyses of the treatment of overanticoagulated patients.

Duong TM, Plowman BK, Morreale AP, Janetzky K.

Pharmacotherapy. 1998 Nov-Dec;18(6):1264-70.

PMID:
9855325
5.

Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement.

Ageno W, Turpie AG, Steidl L, Ambrosini F, Cattaneo R, Codari RL, Nardo B, Venco A.

Am J Cardiol. 2001 Jul 1;88(1):40-4.

PMID:
11423056
6.

Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin.

Woods K, Douketis JD, Kathirgamanathan K, Yi Q, Crowther MA.

J Thromb Thrombolysis. 2007 Oct;24(2):93-7. Epub 2007 Mar 23.

PMID:
17380255
7.

Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.

Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, Hylek EM, Crowther MA; Warfarin-Associated Research Projects and Other Endeavors Consortium.

Pharmacotherapy. 2008 Aug;28(8):960-7. doi: 10.1592/phco.28.8.960.

PMID:
18657012
8.

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E.

Chest. 2004 Sep;126(3 Suppl):204S-233S. Erratum in: Chest. 2005 Jan;127(1):415-6. Dosage error in article text.

PMID:
15383473
9.
10.

Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.

Crowther MA, Douketis JD, Schnurr T, Steidl L, Mera V, Ultori C, Venco A, Ageno W.

Ann Intern Med. 2002 Aug 20;137(4):251-4.

PMID:
12186515
11.

Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin.

Wittkowsky AK, Devine EB.

Pharmacotherapy. 2004 Oct;24(10):1311-6.

PMID:
15628828
12.

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE.

Arch Intern Med. 2000 Jun 12;160(11):1612-7.

PMID:
10847254
13.

Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.

Bussey HI, Bussey M, Bussey-Smith KL, Frei CR.

Pharmacotherapy. 2013 Nov;33(11):1136-46. doi: 10.1002/phar.1343. Epub 2013 Aug 22.

PMID:
24038412
14.

Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio.

Banet GA, Waterman AD, Milligan PE, Gatchel SK, Gage BF.

Chest. 2003 Feb;123(2):499-503.

PMID:
12576372
15.

Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trial.

Kurnik D, Loebstein R, Rabinovitz H, Austerweil N, Halkin H, Almog S.

Thromb Haemost. 2004 Nov;92(5):1018-24.

PMID:
15543329
16.

Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.

Yasaka M, Sakata T, Naritomi H, Minematsu K.

Thromb Res. 2005;115(6):455-9.

PMID:
15792675
17.

Vitamin K supplementation to decrease variability of International Normalized Ratio in patients on vitamin K antagonists: a literature review.

Ford SK, Moll S.

Curr Opin Hematol. 2008 Sep;15(5):504-8. doi: 10.1097/MOH.0b013e328304b3c5. Review.

PMID:
18695375
18.

Evaluation of very low-dose subcutaneous vitamin K during postoperative warfarin therapy.

Possidente CJ, Howe JG, Cushman M.

Pharmacotherapy. 2001 Mar;21(3):295-300.

PMID:
11253854
19.

Atmospheric pressure changes and unexplained variability in INR measurements.

Ernst ME, Shaw RF, Ernst EJ, Alexander B, Kaboli PJ.

Blood Coagul Fibrinolysis. 2009 Jun;20(4):263-70. doi: 10.1097/MBC.0b013e3283257ffc.

PMID:
19300239
20.

Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.

Crowther MA, Donovan D, Harrison L, McGinnis J, Ginsberg J.

Thromb Haemost. 1998 Jun;79(6):1116-8.

PMID:
9657434
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk